Fresh Tracks Therapeutics, Inc.
FRTX · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $5 | $4 | $18 | $19 |
| - Cash | $11 | $9 | $27 | $30 |
| + Debt | $0 | $0 | $0 | $1 |
| Enterprise Value | -$6 | -$4 | -$8 | -$10 |
| Revenue | $8 | $7 | $0 | $2 |
| % Growth | 15.3% | 1,618.6% | -77.8% | – |
| Gross Profit | $8 | -$7 | -$28 | -$9 |
| % Margin | 100% | -102.3% | -6,887.9% | -515.6% |
| EBITDA | -$6 | -$21 | -$39 | -$21 |
| % Margin | -70.5% | -303.4% | -9,748.3% | -1,147.3% |
| Net Income | -$6 | -$21 | -$40 | -$21 |
| % Margin | -71.1% | -297.6% | -9,782.4% | -1,147.3% |
| EPS Diluted | -0.96 | -7.36 | -22.14 | -38.37 |
| % Growth | 87% | 66.8% | 42.3% | – |
| Operating Cash Flow | -$4 | -$19 | -$36 | -$20 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$4 | -$19 | -$36 | -$20 |